Context The long-term risk of suicide after a first episode of psychosis is unknown because
previous studies often have been based on prevalence cohorts, been biased to more …

Objective The aim was to examine the general outcome of schizophrenia after 20 years or
more. Methods Using the PRISMA guidelines, we conducted a systematic review and meta …

AimsThere is evidence that patients with schizophrenia spectrum disorders present higher
mortality in comparison with the general population. The aim of this study was to analyse the …

Background The psychiatry literature routinely quotes a lifetime schizophrenia suicide
prevalence of 10% based on 1 meta-analysis and 2 studies of chronic schizophrenics …

CONTEXT: The rate of health care and palliative care utilization for patients with
schizophrenia near the end-of-life is currently unknown. OBJECTIVE: Compare rate of …

Objective: Although mortality related to psychotropic medications has received much
attention in recent years, little is known about the relationship between risk of death and …

Background It is well established that persons with schizophrenia have high mortality rates.
There is conflicting evidence that antipsychotic and perhaps other medications routinely …

BackgroundCare for people with schizophrenia should address a wide range of outcomes,
including professional and consumer perspectives. AimsTo measure changes in …

Background: The outcome of schizophrenia and related psychoses is generally modest, and
patients display high rates of disability. Aims: The aim of the review is to present an up-to …

BackgroundPrevious studies have reported conflicting results on the association between
schizophrenia and cancer mortality. AimsTo summarise available evidence and quantify the …